Customer Guest RE-KYC
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Customer Guest
Login | Register
Login | Register|Forgot password?
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Copy of Newspaper Publicationmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Business Responsibility & Sustainability Report .more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding Notice of Annual General Meeting to be held on August 25 2025more...
As of June 2025 65.99% is owned by Indian Promoters and 34.01% by Public. Top four Promoters holding highest number of shares of Balaxi Pharmaceutica...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Windowmore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Tradi...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Investor Presentationmore...
The company reported standalone net loss during the quarter stood at Rs 1.18 crore as compared to net loss of Rs 0.58 crore in the previous ...more...
BALAXI Overseas Private LIMITED?has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Boa...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Tran...more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32more...
Integrated Filing(Financial)more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about re-appointment of Internal Auditors of the Companymore...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about appointment of Secretarial auditorsmore...
BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange the financial results for the period ended March 31 2025.more...
BALAXI PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2025 to consider and approve the Yearly Audited Fin...more...
As of March 2025 65.99% is owned by Indian Promoters and 34.01% by Public. Top four Promoters holding highest number of shares of Balaxi Pha...more...
Enter Stock
BOARD MEETINGS Company Name : Andhra Sugars Date : 09-08-2025